Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): a randomised controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica
Published inHealth Technology Assessment, vol. 21, no. 60, p. 1-180
Publication date2017
Abstract
Keywords
- Adalimumab/administration & dosage
- Anti-Inflammatory Agents/administration & dosage
- Cost-Benefit Analysis
- Humans
- Injections, Subcutaneous
- Patient Selection
- Physical Therapy Modalities
- Pilot Projects
- Sciatica/drug therapy
- Treatment Outcome
Affiliation entities
Citation (ISO format)
WILLIAMS, Nefyn H et al. Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): a randomised controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica. In: Health Technology Assessment, 2017, vol. 21, n° 60, p. 1–180. doi: 10.3310/hta21600
Main files (1)
Article (Published version)
Identifiers
- PID : unige:110936
- DOI : 10.3310/hta21600
- PMID : 29063827
ISSN of the journal1366-5278